These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 33372033)

  • 1. Altered Fast Synaptic Transmission in a Mouse Model of DNM1-Associated Developmental Epileptic Encephalopathy.
    McCabe MP; Shore AN; Frankel WN; Weston MC
    eNeuro; 2021; 8(2):. PubMed ID: 33372033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamin 1 isoform roles in a mouse model of severe childhood epileptic encephalopathy.
    Asinof S; Mahaffey C; Beyer B; Frankel WN; Boumil R
    Neurobiol Dis; 2016 Nov; 95():1-11. PubMed ID: 27363778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Independent Neuronal Origin of Seizures and Behavioral Comorbidities in an Animal Model of a Severe Childhood Genetic Epileptic Encephalopathy.
    Asinof SK; Sukoff Rizzo SJ; Buckley AR; Beyer BJ; Letts VA; Frankel WN; Boumil RM
    PLoS Genet; 2015 Jun; 11(6):e1005347. PubMed ID: 26125563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNAi-Based Gene Therapy Rescues Developmental and Epileptic Encephalopathy in a Genetic Mouse Model.
    Aimiuwu OV; Fowler AM; Sah M; Teoh JJ; Kanber A; Pyne NK; Petri S; Rosenthal-Weiss C; Yang M; Harper SQ; Frankel WN
    Mol Ther; 2020 Jul; 28(7):1706-1716. PubMed ID: 32353324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. De novo DNM1 mutations in two cases of epileptic encephalopathy.
    Nakashima M; Kouga T; Lourenço CM; Shiina M; Goto T; Tsurusaki Y; Miyatake S; Miyake N; Saitsu H; Ogata K; Osaka H; Matsumoto N
    Epilepsia; 2016 Jan; 57(1):e18-23. PubMed ID: 26611353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dynamin-1-related infantile spasms: a case report and review of literature].
    Deng XL; Yin F; Zhang CL; Ma YP; He F; Wu LW; Peng J
    Zhonghua Er Ke Za Zhi; 2016 Nov; 54(11):856-859. PubMed ID: 27806796
    [No Abstract]   [Full Text] [Related]  

  • 7. De novo mutations in synaptic transmission genes including DNM1 cause epileptic encephalopathies.
    ; ;
    Am J Hum Genet; 2014 Oct; 95(4):360-70. PubMed ID: 25262651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal axonal development and severe epileptic phenotype in Dynamin-1 (DNM1) encephalopathy.
    Matsubara K; Kuki I; Ishioka R; Yamada N; Fukuoka M; Inoue T; Nukui M; Okamoto N; Mizuguchi T; Matsumoto N; Okazaki S
    Epileptic Disord; 2024 Feb; 26(1):139-143. PubMed ID: 38009673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A deep intronic variant in DNM1 in a patient with developmental and epileptic encephalopathy creates a splice acceptor site and affects only transcript variants including exon 10a.
    Harms FL; Weiss D; Lisfeld J; Alawi M; Kutsche K
    Neurogenetics; 2023 Jul; 24(3):171-180. PubMed ID: 37039969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epileptic encephalopathy-causing mutations in DNM1 impair synaptic vesicle endocytosis.
    Dhindsa RS; Bradrick SS; Yao X; Heinzen EL; Petrovski S; Krueger BJ; Johnson MR; Frankel WN; Petrou S; Boumil RM; Goldstein DB
    Neurol Genet; 2015 Jun; 1(1):e4. PubMed ID: 27066543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of cell, circuit and seizure phenotypes in a mouse model of DNM1 epileptic encephalopathy.
    Bonnycastle K; Dobson KL; Blumrich EM; Gajbhiye A; Davenport EC; Pronot M; Steinruecke M; Trost M; Gonzalez-Sulser A; Cousin MA
    Nat Commun; 2023 Aug; 14(1):5285. PubMed ID: 37648685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss-of-function variants in
    Yigit G; Sheffer R; Daana M; Li Y; Kaygusuz E; Mor-Shakad H; Altmüller J; Nürnberg P; Douiev L; Kaulfuss S; Burfeind P; Wollnik B; Brockmann K
    J Med Genet; 2022 Jun; 59(6):549-553. PubMed ID: 34172529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A missense mutation in a highly conserved alternate exon of dynamin-1 causes epilepsy in fitful mice.
    Boumil RM; Letts VA; Roberts MC; Lenz C; Mahaffey CL; Zhang ZW; Moser T; Frankel WN
    PLoS Genet; 2010 Aug; 6(8):. PubMed ID: 20700442
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    von Spiczak S; Helbig KL; Shinde DN; Huether R; Pendziwiat M; Lourenço C; Nunes ME; Sarco DP; Kaplan RA; Dlugos DJ; Kirsch H; Slavotinek A; Cilio MR; Cervenka MC; Cohen JS; McClellan R; Fatemi A; Yuen A; Sagawa Y; Littlejohn R; McLean SD; Hernandez-Hernandez L; Maher B; Møller RS; Palmer E; Lawson JA; Campbell CA; Joshi CN; Kolbe DL; Hollingsworth G; Neubauer BA; Muhle H; Stephani U; Scheffer IE; Pena SDJ; Sisodiya SM; Helbig I; ;
    Neurology; 2017 Jul; 89(4):385-394. PubMed ID: 28667181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Truncated DNM1 variant underlines developmental delay and epileptic encephalopathy.
    Afsar T; Huang X; Shah AA; Abbas S; Bano S; Mahmood A; Hu J; Razak S; Umair M
    Front Pediatr; 2023; 11():1266376. PubMed ID: 37900685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Both gain-of-function and loss-of-function de novo CACNA1A mutations cause severe developmental epileptic encephalopathies in the spectrum of Lennox-Gastaut syndrome.
    Jiang X; Raju PK; D'Avanzo N; Lachance M; Pepin J; Dubeau F; Mitchell WG; Bello-Espinosa LE; Pierson TM; Minassian BA; Lacaille JC; Rossignol E
    Epilepsia; 2019 Sep; 60(9):1881-1894. PubMed ID: 31468518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A recurrent de novo splice site variant involving DNM1 exon 10a causes developmental and epileptic encephalopathy through a dominant-negative mechanism.
    Parthasarathy S; Ruggiero SM; Gelot A; Soardi FC; Ribeiro BFR; Pires DEV; Ascher DB; Schmitt A; Rambaud C; Represa A; Xie HM; Lusk L; Wilmarth O; McDonnell PP; Juarez OA; Grace AN; Buratti J; Mignot C; Gras D; Nava C; Pierce SR; Keren B; Kennedy BC; Pena SDJ; Helbig I; Cuddapah VA
    Am J Hum Genet; 2022 Dec; 109(12):2253-2269. PubMed ID: 36413998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical, Radiological, and Genetic Characterization of a Patient with a Novel Homoallelic Loss-of-Function Variant in
    AlTassan R; AlQudairy H; Alromayan R; Alfalah A; AlHarbi OA; González-Álvarez AC; Arold ST; Kaya N
    Genes (Basel); 2022 Nov; 13(12):. PubMed ID: 36553519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased propensity for infantile spasms and altered neocortical excitation-inhibition balance in a mouse model of down syndrome carrying human chromosome 21.
    Shao LR; Gao F; Chinnasamy V; Kazuki Y; Oshimura M; Reeves RH; Stafstrom CE
    Neurobiol Dis; 2023 Aug; 184():106198. PubMed ID: 37315904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of rare variant transmission disequilibrium tests to epileptic encephalopathy trio sequence data.
    ; ;
    Eur J Hum Genet; 2017 Jun; 25(7):894-899. PubMed ID: 28513609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.